Last updated on February 2017

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation


Brief description of study

This study evaluates NP001 in patients with amyotrophic lateral sclerosis (ALS) and evidence of systemic inflammation. Half of participants will receive NP001 and the other half will receive placebo.

Detailed Study Description

This is a randomized, double-blind, placebo-controlled study of NP001 in subjects with ALS and evidence of elevated systemic inflammation. Subjects will be allocated (1:1) to NP001 and placebo. Drug or placebo will be given intravenously.

Clinical Study Identifier: NCT02794857

Contact Investigators or Research Sites near you

Start Over

Shafeeq Ladha, MD

St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics
Phoenix, AZ United States
  Connect »

Mark Ross, MD

Mayo Clinic Arizona
Scottsdale, AZ United States
  Connect »

Richard Lewis, MD

Cedars-Sinai Medical Center
Los Angeles, CA United States
  Connect »

Namita Goyal, MD

University of California, Irvine, Department of Neurology
Orange, CA United States
  Connect »

Jonathan S. Katz, MD

Forbes Norris MDA/ALS Research Center, CPMC
San Francisco, CA United States
  Connect »

Bjorn E. Oskarsson, MD

Mayo Clinic Florida
Jacksonville, FL United States
  Connect »

Michael Benatar, MD

University of Miami Miller School of Medicine
Miami, FL United States
  Connect »

Christina Fournier, MD

Emory University, Department of Neurology
Atlanta, GA United States
  Connect »

Richard J. Barohn, MD

University of Kansas Medical Center
Kansas City, KS United States
  Connect »

Edward J. Kasarskis, MD, PhD

University of Kentucky, Albert B. Chandler Medical Center
Lexington, KY United States
  Connect »

James Berry, MD, MPH

Massachusetts General Hospital
Boston, MA United States
  Connect »

Georgios Manousakis, MD

Clinical & Translational Science Institute, University of Minnesota
Minneapolis, MN United States
  Connect »

Benjamin Brooks, MD

Carolinas Medical Center, Neurosciences Instutite-Neurology
Charlotte, NC United States
  Connect »

Richard Bedlack, MD, PhD, MS

Duke Neurological Disorders Clinic at Morreene Road
Durham, NC United States
  Connect »

Erik P. Pioro, MD, PhD

Cleveland Clinic Foundation-Cleveland Clinic Hospital
Cleveland, OH United States
  Connect »

Kimberly Goslin, MD, PhD

Providence Brain & Spine Institute, ALS Center
Portland, OR United States
  Connect »

Ericka Simpson, MD

Houston Methodist Neurological Institute
Houston, TX United States
  Connect »

Angela Genge, MD

Montreal Neurological Institute
Montreal, QC Canada
  Connect »